Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,593 public trials 1,039 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

NCT00104910

Conditions
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, +19 more
Locations
  • Georgia Regents University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Completed

Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer

NCT00054444

Conditions
Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Female Urogenital Diseases, +17 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • University of Missouri - Ellis Fischel Columbia, Missouri, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
View Trial Details
Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086

Conditions
Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • Riverside Methodist Hospital Columbus, Ohio, United States
View Trial Details
Completed

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

NCT00352300

Conditions
Adnexal Diseases, Agranulocytosis, Communicable Diseases, +32 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • New York University Langone Medical Center New York, United States
View Trial Details
Completed

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

NCT01294293

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
Locations
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View Trial Details
Completed

Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer

NCT00390611

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Gulfcoast Oncology Associates St. Petersburg, Florida, United States
View all 17 locations
View Trial Details

Related conditions